Projects per year
Personal profile
Biography
Mark Cooper AO is Professor of Diabetes and head of the Department of Diabetes within the School of Translational Medicine. His research and clinical interests are in diabetes and its complications, including kidney disease, heart disease and blindness.
Biography
Links:
- Department of Diabetes: www.med.monash.edu.au/cecs/diabetes/
- Professor Mark Cooper: www.med.monash.edu.au/cecs/diabetes/staff/cooper-mark.html
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Diabetes
- Diabetic Complications
- kidney disease
- heart disease
- blindness
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Meydan Family Foundation Diabetes Complications Research Hub
Cooper, M. (Primary Chief Investigator (PCI)), Jane, S. (Chief Investigator (CI)) & Mitchell, C. (Chief Investigator (CI))
31/12/16 → 31/12/25
Project: Research
-
Splice switching oligonucleotides for the treatment of chronic kidney disease
Thomas, M. (Primary Chief Investigator (PCI)), Wilton, S. (Chief Investigator (CI)), Wraight, C. (Chief Investigator (CI)), Pickering, R. (Chief Investigator (CI)), Cooper, M. (Associate Investigator (AI)), Coughlan, M. (Associate Investigator (AI)), Tesch, G. (Associate Investigator (AI)), Kitching, R. (Associate Investigator (AI)) & Jupp, B. (Associate Investigator (AI))
1/01/23 → 31/12/25
Project: Research
-
Human pancreatic ductal cell-driven beta-cell regeneration
El-Osta, S. (Primary Chief Investigator (PCI)), Cooper, M. (Chief Investigator (CI)), Al-Hasani, K. (Chief Investigator (CI)), Loudovaris, T. (Associate Investigator (AI)) & Khurana, I. (Associate Investigator (AI))
1/02/22 → 31/01/23
Project: Research
-
Point of care detection of early kidney disease using infrared spectroscopy
Jandeleit-Dahm, K. (Primary Chief Investigator (PCI)), Wood, B. (Chief Investigator (CI)), Cooper, M. (Chief Investigator (CI)), Shaw, J. (Chief Investigator (CI)), Brown, A. D. H. (Chief Investigator (CI)) & Ekinci, E. (Chief Investigator (CI))
Australian Diabetes Society Limited (trading as Diabetes Feet Australia)
1/01/22 → 31/12/22
Project: Research
-
New strategy to safely and effectively reduce diabetic kidney disease
Chai, Z.-L. (Primary Chief Investigator (PCI)), Chalmers, D. (Chief Investigator (CI)) & Cooper, M. (Associate Investigator (AI))
1/01/22 → 31/12/25
Project: Research
-
Induced Genetic Deletion of Cell Division Autoantigen 1 in Adulthood Attenuates Diabetes-Associated Renal Fibrosis
Huynh, P., Yang, Y., Tian, H., Wu, T., Huang, M., Tang, J., Dai, A., Cooper, M. E. & Chai, Z., Mar 2025, In: International Journal of Molecular Sciences. 26, 5, 16 p., 2022.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Kidney Disease: The Forgotten Legacy of Type 1 Diabetes
Thomas, M. C., Zoungas, S., Hanssen, N. M. J., McAuley, S. A. & Cooper, M. E., Aug 2025, In: Diabetes Care. 48, 8, p. 1299-1308 10 p.Research output: Contribution to journal › Review Article › Research › peer-review
2 Citations (Scopus) -
The prognostic impact of the Stress Hyperglycemia Ratio on End-Stage Renal Disease among patients with Diabetic Kidney Disease
Zou, Y., Yang, Q., Lang, Y., Liu, K., Yuan, J., Yang, J., Chai, Z., Cooper, M. E. & Liu, F., Feb 2025, In: Diabetes, Obesity and Metabolism. 27, 2, p. 629-641 13 p.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia
Adeshara, K., Di Marco, E., Bordino, M., Gordin, D., Bernardi, L., Cooper, M. E., Groop, P. H. & on behalf of the FinnDiane Study Group, 28 Sept 2024, In: Cardiovascular Diabetology. 23, 1, 11 p., 350.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
A review of the latest real-world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?
Bonnet, F., Cooper, M. E., Kopp, L., Fouque, D. & Candido, R., Nov 2024, In: Diabetes, Obesity and Metabolism. 26, S6, p. 55-65 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access7 Citations (Scopus)
Activities
- 1 Patents
-
Baker Heart and Diabetes Institute (External organisation)
Chai, Z.-L. (Inventor) & Cooper, M. (Inventor)
29 Jul 2010Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
Press/Media
-
7NEWS interview- Surprise health benefits linked to weight-loss drug
12/12/23
1 Media contribution
Press/Media: Profile/Interview
-
Ten News Melbourne interview- New Founds Benefits of Ozempic for Kidney & Heart Disease
12/12/23
1 Media contribution
Press/Media: Profile/Interview